AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and ...
Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine in first line unfit ...
Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...
A new Yale-led study published Thursday identified a new target for treating the most common form of cancer in children and ...
The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...
Caregivers of individuals diagnosed with acute leukemia face a difficult balancing act: meeting the urgent demands of cancer ...
Daiichi Sankyo is eying new horizons for its leukemia med Vanflyta, with Genesis Pharma signing on to commercialize the drug ...
Pirtobrutinib (Jaypirca®), a first-in-class noncovalent Bruton tyrosine kinase (BTK) inhibitor, has been approved by the FDA ...
Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations -- Program will ...
Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia ...
WASHINGTON — Tatiana Schlossberg, one of three grandchildren of the late President John F. Kennedy, has died at the age of 35 after a battle with cancer. Schlossberg's family disclosed her death in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback